These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 19098285

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.
    Torres S, Garcia-Palmero I, Herrera M, Bartolomé RA, Peña C, Fernandez-Aceñero MJ, Padilla G, Peláez-García A, Lopez-Lucendo M, Rodriguez-Merlo R, García de Herreros A, Bonilla F, Casal JI.
    Clin Cancer Res; 2015 Nov 01; 21(21):4892-902. PubMed ID: 26206869
    [Abstract] [Full Text] [Related]

  • 23. A proteomics approach to identify changes in protein profiles in pre-cancerous colon.
    Drew JE, Rucklidge GJ, Duncan G, Lufty A, Farquharson AJ, Reid MD, Russell WR, Morrice PC, Arthur JR, Duthie GG.
    Biochem Biophys Res Commun; 2005 Apr 29; 330(1):81-7. PubMed ID: 15781235
    [Abstract] [Full Text] [Related]

  • 24. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.
    Minoo P, Zlobec I, Peterson M, Terracciano L, Lugli A.
    Int J Oncol; 2010 Sep 29; 37(3):707-18. PubMed ID: 20664940
    [Abstract] [Full Text] [Related]

  • 25. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P, Liu YX, Chen L, Liu XH, Xiao ZQ, Zhao L, Li GQ, Zhou J, Ding YQ, Li JM.
    J Proteome Res; 2010 Oct 01; 9(10):4897-905. PubMed ID: 20806969
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells.
    Gouyer V, Fontaine D, Dumont P, de Wever O, Fontayne-Devaud H, Leteurtre E, Truant S, Delacour D, Drobecq H, Kerckaert JP, de Launoit Y, Bracke M, Gespach C, Desseyn JL, Huet G.
    Oncogene; 2008 Jul 03; 27(29):4024-33. PubMed ID: 18317448
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Focus on 16p13.3 Locus in Colon Cancer.
    Mampaey E, Fieuw A, Van Laethem T, Ferdinande L, Claes K, Ceelen W, Van Nieuwenhove Y, Pattyn P, De Man M, De Ruyck K, Van Roy N, Geboes K, Laurent S.
    PLoS One; 2015 Jul 03; 10(7):e0131421. PubMed ID: 26222184
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.
    Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L, Chen P, Tong A, Tang M, Gao F, Shen J, Zhang Y, Bai J, Zhou M, Miao D, Chen Q.
    Mol Cell Proteomics; 2008 Sep 03; 7(9):1639-50. PubMed ID: 18458027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.